Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Carla de Sanctis Pecora, Maria Valéria Bussamara Pinheiro, Karin Ventura Ferreira, Gisele Jacobino de Barros Nunes & Hélio Amante Miot. (2021) The One21 Technique: An Individualized Treatment for Glabellar Lines Based on Clinical and Anatomical Landmarks. Clinical, Cosmetic and Investigational Dermatology 14, pages 97-105.
Read now
Read now
Souphiyeh Samizadeh & Koenraad De Boulle. (2018) Botulinum neurotoxin formulations: overcoming the confusion. Clinical, Cosmetic and Investigational Dermatology 11, pages 273-287.
Read now
Read now
Tatjana Pavicic, Welf Prager, Markus Klöppel, Simon Ravichandran & Olivier Galatoire. (2015) IncobotulinumtoxinA use in aesthetic indications in daily practice: a European multicenter, noninterventional, retrospective study. Clinical, Cosmetic and Investigational Dermatology 8, pages 135-142.
Read now
Read now
Mitchell F Brin, Charmaine James & John Maltman. (2014) Botulinum toxin type A products are not interchangeable: a review of the evidence. Biologics: Targets and Therapy 8, pages 227-241.
Read now
Read now
Articles from other publishers (45)
Yan Wu, Fang Fang, Wei Lai, Chengxin Li, Li Li, Quanzhong Liu, Jianyun Lu, Xiaowen Pang, Jiaming Sun, Xiaofeng Shi, Philippe Picaut, Inna Prygova, Bill Andriopoulos & Qiuning Sun. (2022) Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study. Aesthetic Plastic Surgery 47:1, pages 351-364.
Crossref
Crossref
Nowell Solish, Benjamin Ascher, Rui L Avelar, Vince Bertucci, Isaac Bodokh, Jean Carruthers, Hugues Cartier, Henry Delmar, Ralf Denfeld, Marc Heckmann, Per Hedén, Said Hilton, Christopher Inglefield, Patricia Ogilvie, Berthold-Josef Rzany, Gerhard Sattler, Michael Sebastian, Arthur Swift & Patrick Trévidic. (2022) PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data. Aesthetic Surgery Journal 42:12, pages 1460-1469.
Crossref
Crossref
Monica Bravo, Kelly Vogel, Whitney Sternfels, Natalie Touchet & Mamina Turegano. (2022) Botulax and the US development. Dermatological Reviews 3:4, pages 231-235.
Crossref
Crossref
Annica C. Eells, Lisa D. Grunebaum & Brittany E. Howard. (2022) Incobotulinum toxin A: A shelf‐stable, low‐molecular‐weight formulation. Dermatological Reviews 3:4, pages 211-217.
Crossref
Crossref
Kevin R. Patel, Ashley Riddle, Matthew Arffa & S. Tyler Hollmig. (2022) A review on the history, use, and new developments of abobotulinumtoxinA (Dysport). Dermatological Reviews 3:4, pages 197-210.
Crossref
Crossref
Claudia Ledda, Carlo Alberto Artusi, Antonella Tribolo, Domiziana Rinaldi, Gabriele Imbalzano, Leonardo Lopiano & Maurizio Zibetti. (2022) Time to onset and duration of botulinum toxin efficacy in movement disorders. Journal of Neurology 269:7, pages 3706-3712.
Crossref
Crossref
Vasanop Vachiramon, Tanaporn Anuntrangsee, Pasita Palakornkitti, Natthachat Jurairattanaporn & Sarawin Harnchoowong. (2022) Incobotulinum Toxin Type A for Treatment of Ultraviolet-B-Induced Hyperpigmentation: A Prospective, Randomized, Controlled Trial. Toxins 14:6, pages 417.
Crossref
Crossref
Napamon Supornpun, Paisal Rummaneethorn, Thamthiwat Nararatwanchai, Tawee Saiwichai & Sirinthip Chaichalotornkul. (2022) Incobotulinum toxin A with a one-year long-lasting effect for trapezius contouring and superior efficacy for the treatment of trapezius myalgia. Journal of Cutaneous and Aesthetic Surgery 15:2, pages 168.
Crossref
Crossref
Ya.A. Yutskovskaya, A.V. Saybel, L.R. Chakhoyan, A.A. Supilnikov, T.A. Ovcharenko, A.Yu. Terentyev & E.A. Mishurinskaya. (2022) Variable anatomy of facial muscles in the light of botulinum toxin injections. Plasticheskaya khirurgiya i esteticheskaya meditsina:4, pages 102.
Crossref
Crossref
Niamh Corduff. (2022) Sensory Symptoms Associated with Aesthetic Botulinum Toxin A Treatments. Plastic and Reconstructive Surgery - Global Open 10:11, pages e4631.
Crossref
Crossref
Raja Mehanna & Joseph Jankovic. 2022. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1095
1143
.
Arthur Thomas, Natasha MirzaSteven J. Eliades. (2020) Auditory Feedback Control of Vocal Pitch in Spasmodic Dysphonia. The Laryngoscope 131:9, pages 2070-2075.
Crossref
Crossref
Joely Kaufman-Janette, Sue Ellen Cox, Steven Dayan & John Joseph. (2021) Botulinum Toxin Type A for Glabellar Frown Lines: What Impact of Higher Doses on Outcomes?. Toxins 13:7, pages 494.
Crossref
Crossref
Cristina Pires Camargo, Jun Xia, Caroline S Costa, Rolf Gemperli, Maria DC Tatini, Max K Bulsara & Rachel Riera. (2021) Botulinum toxin type A for facial wrinkles. Cochrane Database of Systematic Reviews 2022:1.
Crossref
Crossref
A.A. Sharova. (2021) Pharmacokinetic characteristics of botulinum toxin type A. Plasticheskaya khirurgiya i esteticheskaya meditsina:1, pages 67.
Crossref
Crossref
V.Yu. Avtomonov & E.A. Razumovskaya. (2021) Botulinum toxins in cosmetology: clarifications. Klinicheskaya dermatologiya i venerologiya 20:4, pages 135.
Crossref
Crossref
Christian Murray & Nowell Solish. 2021. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
656
664.e2
.
Raja Mehanna & Joseph Jankovic. 2021. Handbook of Neurotoxicity. Handbook of Neurotoxicity
1
48
.
Mark S. Nestor, David Arnold & Daniel Fischer. (2020) The mechanisms of action and use of botulinum neurotoxin type A in aesthetics: Key Clinical Postulates II. Journal of Cosmetic Dermatology 19:11, pages 2785-2804.
Crossref
Crossref
Joseph Sebastian, Nanditha Hegde, Jibin Skaria, Pradeep P George & Tony Michael. (2020) Botulinum Toxin Type-A for the Treatment of Excessive Gingival Display on Smiling. The Journal of Contemporary Dental Practice 21:9, pages 1018-1021.
Crossref
Crossref
David Rupp, Greg Nicholson, David Canty, Joanne Wang, Catherine Rhéaume, Linh Le, Lance E. Steward, Mark Washburn, Birgitte P. Jacky, Ron S. Broide, Wolfgang G. Philipp-Dormston, Mitchell F. Brin & Amy Brideau-Andersen. (2020) OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays. Toxins 12:6, pages 393.
Crossref
Crossref
Hermine Warren, Kim Welch & Sarah Coquis-Knezek. (2020) AbobotulinumtoxinA for Facial Rejuvenation: What Affects the Duration of Efficacy?. Plastic Surgical Nursing 40:1, pages 37-44.
Crossref
Crossref
Peter Arne Gerber & Said Hilton. 2020. Botulinumtoxin in der ästhetischen Dermatologie. Botulinumtoxin in der ästhetischen Dermatologie
3
13
.
Erin Alouf, Tina Murphy & Gregory Alouf. (2019) Botulinum Toxin Type A: Evaluation of Onset and Satisfaction. Plastic Surgical Nursing 39:4, pages 148-156.
Crossref
Crossref
Rodrigo Tomazini Martins, Kristen E. Elstner, Christian Skulina, Omar Rodriguez-Acevedo, John W. Read, Dominic B. Rowe & Nabeel Ibrahim. (2019) Limitations of Electromyography in the Assessment of Abdominal Wall Muscle Contractility Following Botulinum Toxin A Injection. Frontiers in Surgery 6.
Crossref
Crossref
Mona Ascha, Marco A Swanson, Jonathan P Massie, Morgan W Evans, Christopher Chambers, Brian A Ginsberg, James Gatherwright, Thomas Satterwhite, Shane D Morrison & Alexander J Gougoutas. (2019) Nonsurgical Management of Facial Masculinization and Feminization. Aesthetic Surgery Journal 39:5, pages NP123-NP137.
Crossref
Crossref
Murad Alam, Amelia Geisler, Melanie Warycha, Kapila Paghdal, Wanjarus Roongpisuthipong, Daniel I. Schlessinger, Brian R. Chen, Kelly A. Reynolds, Dennis P. West & Emily Poon. (2019) Effect of postinjection facial exercise on time of onset of botulinum toxin for glabella and forehead wrinkles: A randomized, controlled, crossover clinical trial. Journal of the American Academy of Dermatology 80:4, pages 1144-1147.
Crossref
Crossref
Christopher C. Lo, Ashley Campbell & Joseph A. Eviatar. 2019. Oculofacial, Orbital, and Lacrimal Surgery. Oculofacial, Orbital, and Lacrimal Surgery
403
418
.
Sinyoung Song, Yeon Hoon Lee, Joon Pio Hong & Tae Suk Oh. (2018) Safety, efficacy, and onset of a novel botulinum toxin type A (Nabota) for the treatment of glabellar frown lines: a single-arm, prospective, phase 4 clinical study. Archives of Craniofacial Surgery 19:3, pages 168-174.
Crossref
Crossref
Erin Alouf, Tina Murphy & Gregory Alouf. (2018) Botulinum Toxin Type A: Evaluation of Onset and Satisfaction. Plastic Surgical Nursing 38:3, pages 105-113.
Crossref
Crossref
Mark S. NestorRaymond E. KleinfelderAndy Pickett. (2017) The Use of Botulinum Neurotoxin Type A in Aesthetics: Key Clinical Postulates. Dermatologic Surgery 43:3, pages S344-S362.
Crossref
Crossref
William P. ColemanGerhard SattlerPetra WeissenbergerMichael A. Hast & Angelika Hanschmann. (2017) Safety of IncobotulinumtoxinA in the Treatment of Facial Lines: Results From a Pooled Analysis of Randomized, Prospective, Controlled Clinical Studies. Dermatologic Surgery 43:3, pages S293-S303.
Crossref
Crossref
Je-Young Park, Nak-Kwan Sung & Jonathan M. Pitt. (2017) Efficacy and Tolerability of IncobotulinumtoxinA for Treating Glabellar Frown Lines in Korean Adults: A Postmarketing Observational Study. Dermatologic Surgery 43:3, pages S304-S311.
Crossref
Crossref
JTE Lim, DK Loh, K Soh & O Sunga. (2017) Efficacy and patient satisfaction with incobotulinumtoxinA for the treatment of glabellar frown lines. Singapore Medical Journal 58:10, pages 606-609.
Crossref
Crossref
Ulrich Kühne & Matthias Imhof. 2017. Botulinum Toxins. Botulinum Toxins
79
95
.
Neal D. Varughese & David J. Goldberg. 2017. Botulinum Toxins. Botulinum Toxins
133
145
.
Welf PragerDiana Nogueira TeixeiraPhillip S. Leventhal. (2017) IncobotulinumtoxinA for Aesthetic Indications: A Systematic Review of Prospective Comparative Trials. Dermatologic Surgery 43:7, pages 959-966.
Crossref
Crossref
José Raúl MontesAnthony J. WilsonBrian L. ChangIvona Percec. (2016) Technical Considerations for Filler and Neuromodulator Refinements. Plastic and Reconstructive Surgery - Global Open 4:12S, pages e1178.
Crossref
Crossref
Marie E. Noland, Donald H. Lalonde, G. Jackie Yee & Rod J. Rohrich. (2016) Current Uses of Botulinum Neurotoxins in Plastic Surgery. Plastic & Reconstructive Surgery 138:3, pages 519e-530e.
Crossref
Crossref
Brian L. Chang, Anthony J. Wilson, Anthony J. Taglienti, Catherine S. Chang, Nancy Folsom & Ivona Percec. (2016) Patient Perceived Benefit in Facial Aesthetic Procedures: FACE-Q as a Tool to Study Botulinum Toxin Injection Outcomes. Aesthetic Surgery Journal 36:7, pages 810-820.
Crossref
Crossref
James P. Bonaparte, David Ellis, Jason G. Quinn, Jessica Rabski & Brian Hutton. (2016) A Comparative Assessment of Three Formulations of Botulinum Toxin Type A for Facial Rhytides: A Systematic Review with Meta-Analyses. Plastic & Reconstructive Surgery 137:4, pages 1125-1140.
Crossref
Crossref
Michael S. Gart & Karol A. Gutowski. (2015) Aesthetic Uses of Neuromodulators. Plastic and Reconstructive Surgery 136, pages 62S-71S.
Crossref
Crossref
Martina Kerscher, Berthold Rzany, Welf Prager, Catriona Turnbull, Patrick Trevidic & Christopher Inglefield. (2015) Efficacy and Safety of IncobotulinumtoxinA in the Treatment of Upper Facial Lines. Dermatologic Surgery 41:10, pages 1149-1157.
Crossref
Crossref
Rashid Kazerooni, Jane Lim, PharmD Ashley Blake & Stephanie Lessig. (2015) IncobotulinumtoxinA for Migraine: A Retrospective Case Series. Clinical Therapeutics 37:8, pages 1860-1864.
Crossref
Crossref
Enrique Garcia-Murray, María Luisa Velasco Villasenor, Berenice Acevedo, Silvia Luna, Jane Lee, Jacob M. Waugh & Carl S. Hornfeldt. (2015) Safety and Efficacy of RT002, an Injectable Botulinum Toxin Type A, for Treating Glabellar Lines. Dermatologic Surgery 41:Supplement 1, pages S47-S55.
Crossref
Crossref